We present a case of multifocal plasmacytoma, one of the rarest hematological malignancies, with an unusual presentation of cervical myelopathy. A 60-year-old male presented with features of cervicalgia and radiculomyelopathy. There was a history of significant weight loss over 2 months with no sphincter involvement. Neurological examination showed spastic quadriparesis with extensor plantars. Radiological workup showed multiple lytic lesions from C3 to C6 with cord compression and myelomalacic changes. The patient underwent three-level corpectomy (C5-C7) with cord decompression. Reconstruction was done with an expandable titanium cage, and anterior cervical plating from C4 to T1 was done. The histopathology and immunohistochemistry markers enabled in clinching this rare diagnosis of multifocal plasmacytoma. It is essential to distinguish early between various entities among plasmacytoma as each one has a different clinical course and prognosis. Multiple solitary plasmacytoma presenting de novo with cord compression and myelopathy is an extremely rare presentation.
Introduction
T he International Myeloma Working Group (2003) classified plasmacytomas into solitary plasmacytoma of the bone (SBP) if single bony lytic lesion is present, solitary extramedullary plasmacytoma (SEP) if solitary extraosseous soft-tissue lesion is present, and multiple solitary plasmacytoma (MSP) if plasma cell infiltrates are found at multiple places in soft tissues, bones, or both. [1] These entities comprise few of the rarest hematological diseases. The incidence of plasmacytoma is 0.35/lakh and comprises only 5%-10% of all plasma cell neoplasms. [1, 2] Of these three varieties, MSP is the rarest. The spinal involvement in MSP usually does not cause cord compression requiring surgical decompression. We report an interesting case of a patient with multifocal solitary plasmacytoma involving several vertebrae in the cervical and dorsal spine with extension into the epidural space causing cervical cord compression. This warranted surgical decompression and spinal fusion. The importance of early diagnosis lies in preventing potential conversion of these plasmacytomas into multiple myeloma (MM). [1] had no lymphadenopathy. His hemogram and routine biochemical parameters were within normal limits. X-ray cervical spine showed multiple lytic lesions from C5 to C7 levels. Computerized tomography (CT) cervical spine showed complete destruction of C6 and C7 vertebral bodies and partial destruction of posterior elements [ Figure 1a ]. Contrast-enhanced magnetic resonance imaging showed paraspinal soft-tissue involvement with significant epidural component causing cord compression at C6-C7 and also involvement of D1, D3 vertebral bodies [ Figure 1b and c].
CT-guided fine-needle aspiration cytology suggested poorly differentiated malignancy. Workup for MM showed no evidence of anemia and deranged renal functions. His calcium level and serum electrophoresis did not reveal any anomaly. Urine was negative for Bence-Jones proteins.
Besides MM workup, metastasis workup was also done. His serum prostate-specific antigen (PSA), carcinoembryonic antigen, and cancer antigen 19-9 were all within normal limits. Ultrasound (USG) abdomen and pelvis, contrast-enhanced CT chest and abdomen, and positron emission tomography scan showed no features of extramedullary involvement or any other neoplastic lesion.
In view of significant cervical cord compression causing myelopathy, he underwent three-level corpectomy (C5-C7) with cord decompression. Stabilization was done with an expandable titanium cage, and anterior plating from C4 to T1 was done. Intraoperative frozen section was suggestive of poorly differentiated malignancy most likely adenocarcinoma. Postoperative imaging showed good neural decompression with stable construct [ Figure 2 ].
Postoperative recovery was uneventful, and at 6 weeks, his spasticity had significantly subsided and was ambulant without support.
Immunohistochemistry (IHC) markers which showed positive results were LCA, CD10, and CD138 along with kappa restriction [ Figure 3 ].
MIB-1 activity was 15%. On this basis, the final diagnosis of plasmacytoma was clinched, and the patient referred for adjuvant chemoradiation.
Discussion
MSP is defined as a monoclonal plasma cell infiltrate in one or more osseous or extramedullary (soft tissues) lesions or both. [1] MSP comprises 5% of initially diagnosed solitary plasmacytomas. [1, 2] It is usually not associated with features of MM such as hypercalcemia, anemia, renal failure, serum and/or urinary monoclonal proteins, or monoclonal light chains. [1] It also does not show evidence of plasma cell proliferation on random iliac crest bone marrow biopsy.
Most of the cases of plasmacytoma described in literature have solitary bone lesion (SBP). In our case, however, multiple vertebral bodies (C2-C7, D1, and D3) were involved. C6 was worst affected and other sites were noncontiguous, thereby making an impression of "multifocal" plasmacytoma. There was also significant cervical cord compression producing symptoms of myelopathy.
Till now, very few cases of MSP have been reported in literature. [3] Collier [4] reported a case of an adult male with MSP who presented with raised intracranial pressure, and lytic lesions were seen on radiographs of the skull, sacrum, and left clavicle.
Katzmann et al. studied 899 patients with plasma cell dyscrasias and monoclonal gammopathies of which only 27 (03%) cases were SBP or SEP and only 3 (0.3%) were MSP. [3] In 2006, Ooi et al. described six patients with MSP, of which four cases were multiple extramedullary plasmacytomas and the other two cases had both osseous and extramedullary lesions. [5] Kulbacki and Wang reported a case of MSP in a young male with lytic lesions of C1, first left rib and hip. [6] The biopsy of the lesion was positive for CD38, CD138, CD56, and κ-light chain but was negative for CD19, CD20, cyclin D1, and λ-light chain.
According to our extensive literature search, no case could be found where MSP was associated with compressive cervical myelopathy and cervical instability although many cases of SBP producing the above features have been reported.
The diagnosis of MSP is by tissue biopsy. [1, 2] Usually, bone marrow biopsy (commonly from iliac crest) shows normocellular bone marrow with only minimal interstitial plasmacytosis (<10% of all nucleated cells), thereby differentiating it from MM. [1, 2] The usual histopathology is that of monomorphic plasma cells, having λ-chains, large "plasmacytoid" cytoplasm and are CD138 positive. IHC evaluation yields positivity for CD38, CD45 (lightly), CD10 (lightly), and λ-light chains along with negativity for CD20, CD3, CD30, CD79a, CD56, anaplastic lymphoma kinase-1, and cytokeratins AE1 and AE3, thereby differentiating it from MM. [1, 2] Histopathological evaluation of our case revealed monomorphous population of large plasma cells with nuclear atypia, clumped chromatin, and prominent nucleoli. IHC assessment revealed positivity for IHC markers such as LCA, CD10, EBER, CD138, KAPPA restriction, and MIB-1 activity was low 15%. It was negative for CK, CK-7, CK-20, HMB-45, PSA, TTF-1, CD3, CD20, CD19, PAX-5, and EMA. On the basis of these detailed radiological, histopathological, and IHC assessments, a diagnosis of "multifocal plasmacytoma" was clinched.
Because of the rarity and heterogeneous presentation of MSP, no clear management guidelines are available. [1, 2, 7] Chemotherapy, radiotherapy, and surgery have been tried with variable results. For MSP, a multimodality treatment including surgery for compressive lesion followed by radiotherapy and chemotherapy is considered optimum. [2, 7] Radiotherapy with 4500-5000-cGy irradiation is known to be effective for local control and longer (>2 years) progression-free survival rates. [2, 7] Thalidomide, bortezomib, and melphalan are useful chemotherapeutic agents that have been studied for treating plasmacytomas with variable results. [7] 
Conclusion
It is very essential to distinguish between various entities among plasmacytoma such as extramedullary plasmacytoma, solitary bone plasmacytoma, and MSP since each has a unique clinical course and prognosis. Spinal involvement in the form of compressive myelopathy as in our case is an extremely rare presentation of MSP.
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